natgillin/translations-raw huggingface dataset:
Sex Male
spol moški
Sexual dysfunction
motnje na področju spolnosti
sexual dysfunction
motnje spolne funkcije
Sexual dysfunction
polna disfunkcija
Sexual dysfunction Amenorrhoea
polne motnje, amenoreja
Sexual dysfunction Scrotal erythema Genital discomfort Genital haemorrhage Pelvic pain
polna disfunkcija eritem skrotuma genitalno nelagodje genitalna krvavitev bolečina v medenici
sexual dysfunction, decreased libido
motnje pri spolnosti, zmanjšan libido
Sexual dysfunction, decreased libido.
spolne motnje, zmanjšana spolna sla
Sexual dysfunction, ejaculation delayed, dysmenorrhoea, breast pain
spolna disfunkcija, zapoznela ejakulacija, dismenoreja, bolečine v dojkah
Sexual dysfunction, for example impotence.
polno disfunkcijo, na primer impotenco,
Sexual intercourse with a vasectomised male partner only; vasectomy must be confirmed by two negative semen analyses
Spolni odnosi samo z moškim partnerjem, ki je imel vazektomijo; vazektomijo je treba potrditi z dvema negativnima analizama sperme
Sexual intercourse without a latex condom
polnim stikom brez lateksnega kondoma,
Sexual Risk Factors at Screening
Dejavniki spolnega tveganja ob presejanju
Sexual stimulation is required for a response to treatment.
Za odziv na zdravljenje je potrebno spolno vzburjenje.
Sexual: a decrease in sex drive; difficulty getting or keeping an erection
Sečila: pogostejše uriniranje kot po navadi
Sexual: drop in levels of sperm
Spolni organi: zmanjšano število semenčic
Sexually active men are recommended to use condoms during treatment and for at least 90 days after cessation of treatment.
Spolno aktivnim moškim je treba svetovati, da uporabljajo kondome med zdravljenjem in najmanj 90 dni po zaključku zdravljenja.
Sexually mature males are advised not to father a child during the treatment, and up to 6 months thereafter.
Spolno zrelim moškim odsvetujemo zaploditev otroka v času zdravljenja in še 6 mesecev zatem.
SF-36 (mean change in mental and physical component scores) was significantly greater with tocilizumab subcutaneous group (6.5 and 5.3) versus placebo (3.8 and 2.9).
Po SF-36 je bila povprečna sprememba od izhodišča za mentalno in fizično komponento ocene značilno večja v skupini s subkutanim tocilizumabom (6,5 in 5,3) v primerjavi s placebom (3,8 in 2,9).
SGLT2 absorbs glucose from the urine into the bloodstream as the blood is filtered in the kidneys.
SGLT2 absorbira glukozo iz urina v krvni obtok, medtem ko se kri filtrira v ledvicah.
SGLT2 absorbs glucose from the urine into the bloodstream as the blood is filtered in the kidneys.
Ta absorbira glukozo iz urina v krvni obtok, medtem ko se kri filtrira v ledvicah.
SGLT2 is a protein that absorbs glucose back from the urine into the bloodstream as the blood is filtered in the kidneys.
SGLT2 je beljakovina, ki absorbira glukozo iz urina nazaj v krvni obtok, medtem ko se kri filtrira v ledvicah.
SGLT2 is a protein that absorbs glucose from the urine into the bloodstream as the blood is filtered in the kidneys.
SGLT2 je beljakovina, ki absorbira glukozo iz urina v krvni obtok, medtem ko se kri filtrira v ledvicah.
SGOT (AST)
Povišanje SGOT (AST)
SGOT increased, hyperuricaemia
zvišana SGOT, hiperurikemija
SGPT (ALT)
Povišanje SGPT (ALT)
SGPT (ALT) elevation
Povišanje SGPT (ALT)
SGPT (ALT) elevation
Utrujenost
SGRQ total score measuring health related quality of life (HRQoL) was analysed at 52 weeks.
Skupni seštevek SGRQ merjenja z zdravjem povezane kakovosti življenja (HRQoL-health related quality of life), je bil analiziran v 52. tednu.
Shake before use
Pred uporabo pretresite
Shake bottle vigorously for 30 seconds, or until all visual settlement has been resuspended.
Pred uporabo močno stresajte vialo 30 sekund oziroma tako dolgo, dokler se vsi vidni delci ne resuspendirajo.
Shake gently before use
Pred uporabo narahlo pretresite
Shake gently before use
Pred uporabo narahlo pretresite.
Shake gently the vial and administer subcutaneously one dose of the veterinary medicinal product according to the following regimen of vaccination.
Vialo rahlo pretresite in subkutano aplicirajte odmerek zdravila za uporabo v veterinarski medicini po naslednjem programu cepljenja.
Shake gently the vial before use.
Pred uporabo vialo rahlo pretresite.
Shake off excess water and leave the disassembled oral syringe to dry until reassemble for next dosing occasion.
Odvečno vodo je treba otresti in pustiti razstavljeno brizgo za peroralno dajanje, da se suši, dokler se je spet ne sestavi za naslednji odmerek.
Shake sachet gently to settle contents.
Vrečico nežno stresite, da se vsebina usede na dno vrečice.
Shake smoothly.
Previdno premešajte.
Shake syringe vigorously for at least 15 seconds
injekcijsko brizgo močno stresajte najmanj 15 sekund
Shake the bottle and twist off the cap.
Pretresite kapalni vsebnik in odvijte zaporko.
Shake the bottle gently
Plastenko narahlo pretresite.
Shake the bottle gently.
Plastenko narahlo pretresite.
Shake the bottle lightly before opening
Pred odmerjanjem rahlo pretresite plastenko.
Shake the bottle vigorously before use.
Pred uporabo plastenko dobro pretresite.
Shake the bottle vigorously for at least 30 seconds to ensure the medicine is well mixed (figure 1).
Steklenico pred uporabo močno pretresajte vsaj 30 sekund, da se zdravilo dobro premeša (Slika 1).
Shake the bottle vigorously prior to each dose.
Vsebnik pred vsakim odmerjanjem močno pretresite.
Shake the bottle well before each use.
Plastenko pred vsako uporabo dobro pretresite.
Shake the bottle well before each use.
Pred vsako uporabo steklenico dobro pretresite.
Shake the closed bottle of constituted suspension for approximately 10 seconds before each use.
Pred vsako uporabo tresite zaprto plastenko s pripravljeno suspenzijo približno 10 sekund.
Shake the nasal spray vigorously with the cap on for about 10 seconds.
Nosno pršilo z nameščenim pokrovčkom približno 10 sekund močno stresajte.
Shake the nasal spray vigorously with the cap on for about 10 seconds.
Pršilo za nos z nameščenim pokrovčkom približno 10 sekund močno stresajte.
Shake the nasal spray vigorously.
Nosno pršilo močno pretresite.
Shake the nasal spray vigorously.
Pršilo za nos močno pretresite.
Shake the oral applicator containing the solvent vigorously.
Peroralni aplikator z vehiklom dobro pretresite.
Shake the pipette thoroughly before use.
Kapalko pred uporabo dobro pretresite.
Shake the pre-filled syringe so that the contents become homogeneous.
Napolnjeno injekcijsko brizgo pretresite, da se vsebina homogenizira.
Shake the product well before mixing.
Pred mešanjem suspenzijo dobro pretresite.
Shake the suspension well and draw the appropriate recommended dose into the dispenser.
Suspenzijo dobro pretresite in dajte priporočeni odmerek v odmernik.
Shake the syringe vigorously for at least 20 seconds to re-suspend prior to injection if the syringe has been left for more than 15 minutes.
Če injekcijske brizge ne uporabite več kot 15 minut po rekonstituciji, jo pred injiciranjem močno stresajte vsaj 20 sekund, da se zdravilo ponovno suspendira.
Shake the syringe vigorously for at least 20 seconds to re-suspend prior to injection if the syringe has been left for more than 15 minutes.
Če injekcijske brizge niste uporabili več kot 15 minut po rekonstituciji, jo pred injiciranjem močno stresajte vsaj 20 sekund, da se zdravilo ponovno suspendira.
Shake the syringe vigorously for at least 20 seconds to re-suspend prior to injection if the syringe has been left for more than 15 minutes.
Če injekcijske brizge niste uporabili več kot 15 minut po rekonstituciji, jo pred injiciranjem močno stresajte vsaj 20 sekund, da zdravilo ponovno suspendira.
Shake the vaccine bottle (1 bottle = 1 dose).
Pretresite steklenico s cepivom (1 steklenica = 1 odmerek).
Shake the vaccine gently before use.
Pred uporabo rahlo pretresite.
Shake the vaccine gently before use.
Rekonstituirano cepivo pred uporabo rahlo pretresite.
Shake the vaccine suspension.
Cepno suspenzijo pretresite.
Shake the vial gently to dissolve the powder, avoiding foaming.
Stekleničko nežno pretresemo, da se prašek stopi, ne da bi se spenil.
Shake the vial of antigen suspension.
Viala z antigenom dobro pretresite.
Shake the vial of antigen suspension.
Vialo z antigenom dobro pretresite.
Shake the vial so that the contents become homogeneous.
Vialo pretresite, da se vsebina homogenizira.
Shake the vial until the powder is seen to have fully dissolved.
Vialo pretresite, dokler se prašek popolnoma ne raztopi.
Shake the vial vigorously before use.
Vialo pred uporabo dobro pretresite.
Shake the vial vigorously for 30 seconds until the suspension appears uniform.
Vialo močno stresajte 30 sekund, dokler suspenzija ni homogena.
Shake the vial vigorously for at least 60 seconds to re-suspend prior to injection.
Vialo pred injiciranjem močno stresajte vsaj 60 sekund, da bi jo ponovno suspendirali.
Shake the vial vigorously prior to use.
Pred uporabo dobro pretresite vialo.
Shake to form a uniform suspension.
Pretresite, da bi dobili enotno suspenzijo.
Shake vigorously before and at intervals during use.
Dobro pretresite pred uporabo in v razmakih med uporabo.
Shake vigorously before use and at intervals during use.
Pred uporabo in občasno med njo dobro pretresite.
Shake vigorously prior to use
Pred uporabo dobro pretresite.
SHAKE VIGOROUSLY.
MOČNO PRETRESITE.
Shake well and administer immediately the entire content (1 ml) of the reconstituted product.
Pred uporabo dobro pretresite in takoj aplicirajte celotno rekonstituirano vsebino viale (1 ml).
Shake well and administer immediately the entire content (1 ml) of the reconstituted product.
Pred uporabo dobro pretresite in takoj dajte celotno rekonstituirano vsebino viale (1 ml).
Shake well and administer immediately the entire content (1 ml) of the reconstituted product.
Pred uporabo dobro pretresite in takoj uporabite celotno rekonstituirano vsebino viale (1 ml).
Shake well and administer immediately the entire contents (1 ml) of the product .
Pred uporabo dobro pretresite in takoj aplicirajte celotno vsebino cepiva (1 ml).
Shake well and administer immediately the entire contents (1 ml) of the product.
Pred uporabo dobro pretresite in takoj aplicirajte celotno vsebino cepiva (1 ml).
Shake well and administer immediately the entire contents (1 ml) of the reconstituted product.
Pred uporabo dobro pretresite in takoj aplicirajte celotno rekonstituirano vsebino viale (1 ml).
Shake well and immediately inject the entire contents (1 ml) of the reconstituted product.
Pred uporabo dobro pretresite in takoj aplicirajte celotno rekonstituirano vsebino viale (1 ml).
Shake well before each use.
Pred vsako uporabo dobro pretresite.
Shake well before use
Pred uporabo dobro pretresite.
Shake well before use to make a suspension.
Pred uporabo dobro pretresite, da nastane suspenzija.
Shake well before use, the pre-filled syringe, to make a suspension.
Napolnjeno injekcijsko brizgo pred uporabo dobro pretresite, da nastane suspenzija.
Shake well before use.
Kapalni vsebnik dobro pretresite pred uporabo.
Shake well before use.
Pred uporabo dobro pretresite
Shake well before use.
Pred uporabo dobro pretresite kapalni vsebnik.
Shake well before use.
Pred uporabo dobro pretresti.
Shake well before use.
Pred uporabo pretresite.
Shake well to dissolve. (See section 6.4.)
Dobro pretresite, da se vse raztopi. (Glejte poglavje 6.4.)
Shaking
omotica tresenje
Shaking
tresenje
Shaking (tremor)
tresenje (tremor)
Shaking (tremor).
tresavica (tremor),
Shaking or tremors, dizziness, fainting or passing out, ear pain, buzzing, ringing or other persistent noise in the ears
tresenje ali tremor, omotica, omedlevica, bolečina v ušesu, brnenje, zvonjenje ali drugačen nenehen zvok v ušesih,
Shaking.
tresenje
Shaking/tremor
tresenje/tresavica, tesnobnost.
Shaking;
tresenje,
Shallow breathing Face swelling Sweatiness Muscle tightness
plitvo dihanje otekanje obraza znojna koža napetost mišic občutek teže
Sham
placebo
Sham (n=238)
placebo (n=238)
Sham- sham/sham+ discontinued
placebo- placebo/placebo
sham-controlled arm crossed-over to ranibizumab
kontrolni bolniki, ki so s placeba prešli na ranibizumab
Sham/Lucentis
študija CRUISE
Shampooing or immersion of the animal in water directly after treatment may reduce the efficacy of the product.
Umivanje s šamponom ali kopanje živali neposredno po nanosu zdravila lahko zmanjšata njegovo učinkovitost.
Shampooing or soaking the animal two hours or more after treatment did not affect the medicine’s effectiveness.
Šamponiranje ali močenje dlake živali dve uri ali več po zdravljenju ni vplivalo na učinkovitost zdravila.
Shanbally, Ringaskiddy, Co. Cork
Shanbally, Ringaskiddy, Co.
Sharp scissors
ostre škarje
Sharp scissors
ostre škarje,
Sharps disposal container
vsebnik za odstranjevanje ostrih predmetov
Sharps disposal container.
Vsebnik za odlaganje ostrih odpadkov.
She acknowledges that she understands the hazards and necessary precautions associated with the use of thalidomide.
Bolnica potrdi, da razume nevarnosti in previdnostne ukrepe, potrebne v zvezi z uporabo talidomida.
She is informed and understands the potential consequences of pregnancy and the need to rapidly consult if there is a risk of pregnancy
Bolnica je obveščena in razume možne posledice nosečnosti in potrebo po takojšnjem posvetovanju, če obstaja tveganje za zanositev.
She is informed and understands the potential consequences of pregnancy and the need to rapidly consult if there is a risk of pregnancy
mora biti obveščena ter razumeti možne posledice nosečnosti in potrebo po takojšnjem posvetu, če obstaja tveganje za zanositev,
She is informed and understands the potential consequences of pregnancy and the need to rapidly consult if there is a risk of pregnancy
mora biti obveščena ter razumeti možne posledice nosečnosti in potrebo po takojšnjem posvetu, če obstaja tveganje za zanositev;
She lf life
Rok uporabnosti
She must not breast-feed while taking Odomzo and for 20 months after the final dose.
če mora zamenjati kontracepcijo, ne sme dojiti v času jemanja zdravila Odomzo in še 20 mesecev po zadnjem odmerku.
She must tell her healthcare provider if any of the following occur during treatment and during the 20 months after her final dose:
mora svojega zdravnika obvestiti, če v času zdravljenja in v 20 mesecih po zadnjem odmerku pride do česarkoli od naslednjega:
She must tell her healthcare provider if any of the following occur during treatment and for 24 months after her final dose:
mora svojega zdravnika obvestiti, če se ji med zdravljenjem ali v 24 mesecih po zadnjem odmerku zdravila zgodi kaj od naslednjega:
She should be capable of complying with effective contraceptive measures
Bolnica mora biti zmožna ravnati v skladu z zanesljivimi kontracepcijskimi ukrepi.
She should be capable of complying with effective contraceptive measures
mora biti zmožna upoštevati zanesljive kontracepcijske ukrepe,
She should be capable of complying with effective contraceptive measures
mora biti zmožna upoštevati zanesljive kontracepcijske ukrepe;
She understands the expected teratogenic risk to the unborn child
razume pričakovano tveganje za teratogene učinke pri nerojenem otroku,
She understands the expected teratogenic risk to the unborn child
razume pričakovano tveganje za teratogene učinke pri nerojenem otroku;
She understands the need and accepts to undergo pregnancy testing every 4 weeks
Bolnica razume potrebo po opravljanju testa nosečnosti vsake 4 tedne in v to privoli.
She understands the need for effective contraception, without interruption, 4 weeks before starting treatment, throughout the entire duration of treatment, and 4 weeks after the end of treatment
Bolnica razume potrebo po zanesljivi kontracepciji brez prekinitev, 4 tedne pred pričetkom zdravljenja, med celotnim trajanjem zdravljenja ter 4 tedne po koncu zdravljenja.
She understands the need for effective contraception, without interruption, 4 weeks before starting treatment, throughout the entire duration of treatment, and 4 weeks after the end of treatment
razume potrebo po zanesljivi kontracepciji, brez prekinitve, 4 tedne pred začetkom zdravljenja, ves čas zdravljenja in 4 tedne po koncu zdravljenja,
She understands the need for effective contraception, without interruption, 4 weeks before starting treatment, throughout the entire duration of treatment, and 4 weeks after the end of treatment
razume potrebo po zanesljivi kontracepciji, brez prekinitve, 4 tedne pred začetkom zdravljenja, ves čas zdravljenja in 4 tedne po koncu zdravljenja;
She understands the need to commence the treatment as soon as lenalidomide is dispensed following a negative pregnancy test
mora razumeti potrebo, da prične z zdravljenjem, brž ko je izdan lenalidomid po negativnem testu nosečnosti;
She understands the need to commence the treatment as soon as pomalidomide is dispensed following a negative pregnancy test
mora razumeti potrebo, da prične z zdravljenjem, brž ko je izdan pomalidomid po negativnem testu nosečnosti,
She understands the need to commence the treatment as soon as thalidomide is dispensed following a negative pregnancy test
Bolnica razume potrebo, da se prične zdravljenje kakor hitro je izdan talidomid po negativnem testu nosečnosti.
She understands the teratogenic risk to the unborn child
Bolnica razume tveganje teratogenih učinkov za nerojenega otroka.
Shedding of skin – increase in redness and shedding of skin over a larger area of the body may be symptoms of erythrodermic psoriasis or exfoliative dermatitis, which are serious skin conditions.
Luščenje kože – močna pordelost in zvečano luščenje kože večjega dela telesa so lahko simptomi eritrodermične psoriaze ali eksfoliativnega dermatitisa, ki sta hudi obolenji kože.
Shedding of the vaccine strain from the injection site can be observed for a period of four days after vaccination.
Cepni sev se lahko izloča iz mesta vboda štiri dni po cepljenju.
Shedding of the vaccine virus by body fluids can not be excluded.
Razsoja virusa cepiva s telesnimi tekočinami ni mogoče izključiti.
Shedding of vaccine virus has however never been observed.
Izločanje virusa iz cepiva ni bilo dokazano, vendar ga ni mogoče izključiti.
Shedding of vaccine virus has however not been detected but cannot be excluded.
Izločanje virusa iz cepiva ni bilo dokazano, vendar ga ni mogoče izključiti.
Sheep
klorobutilno
Sheep and cattle.
Ovce in govedo
Sheep from 1 month of age: injection of a single dose of 1 ml.
Ovce od starosti 1 meseca: enkratni odmerek po 1 ml
Shelf life
0,004
Shelf life
28 (80,0%)
Shelf life
placebo
Shelf life
Rok uporabnosti.
Shelf life after dilution according to directions: 4 hours.
Rok uporabnosti po razredčenju v skladu z navodili: 4 ure.
Shelf life after dilution: See leaflet.
Rok uporabnosti po razredčenju: Glejte navodilo.
Shelf life after dilution: see package leaflet.
Rok uporabnosti po redčenju: glejte navodilo za uporabo.
Shelf life after first broaching the glass vial: 28 days.
Rok uporabnosti po prvem odpiranju vsebnika: 28 dni.
Shelf life after first opening and after dilution for infusion:
Rok uporabnosti po prvem odprtju in redčenju pred infundiranjem:
Shelf life after first opening in the syringes: 8 hours (if space permitted)
Rok uporabnosti po prvem odpiranju v brizgah: 8 ur (če prostor to dovoljuje)
Shelf life after first opening of the bottle: 45 days
Rok uporabnosti po prvem odprtju plastenke: 45 dni
Shelf life after first opening of the bottle: 6 months
Rok uporabnosti po prvem odprtju plastenke: 6 mesecev
Shelf life after first opening of the bottle: 60 days Open date: (Bottle only)
Rok uporabnosti po prvem odprtju plastenke: 60 dni Datum odprtja: (samo na plastenki)
Shelf life after first opening of the immediate packaging: 3 months.
Rok uporabnosti po prvem odpiranju stične ovojnine: 3 mesece
Shelf life after first opening of the immediate packaging: 4 weeks
Rok uporabnosti po prvem odpiranju stične ovojnine: 4 tedne
Shelf life after first opening of the immediate packaging: 4 weeks
Rok uporabnosti po prvem odpiranju stične ovojnine: 4 tedni
Shelf life after first opening of the immediate packaging: 5 weeks Shelf life of the medicated drinking water: 24 hours.
Rok uporabnosti po prvem odpiranju stične ovojnine: 5 tednov
Shelf life after first opening of the immediate packaging: 5 weeks Shelf life of the medicated drinking water: 24 hours.
Rok uporabnosti po prvem odpiranju stične ovojnine: 5 tednov Rok uporabnosti vode za pitje z raztopljenim zdravilom: 24 ur.
Shelf life after first opening of the immediate packaging: 5 weeksMedicated drinking water should be replaced every 24 hours.
Rok uporabnosti po prvem odpiranju stične ovojnine: 5 tednov Medicinirano vodo za pitje je treba zamenjati, če ni porabljena v 24 urah.
Shelf life after first opening of the immediate packaging: use immediately.
Rok uporabnosti po prvem odpiranju stične ovojnine: Uporabite takoj.
Shelf life after first opening the bottle: 6 months.
Rok uporabnosti po prvem odprtju stične ovojnine: 6 mesecev.
Shelf life after first opening the bottle: 8 months.
Rok uporabnosti po prvem odpiranju stične ovojnine: 8 mesecev.
Shelf life after first opening the container: 1 month.
Odprto zdravilo je uporabno 1 mesec.
Shelf life after first opening the container: 1 month.
Rok uporabnosti po prvem odpiranju neposredne ovojnice: 1 mesec.
Shelf life after first opening the container: 10 hours
Rok uporabnosti po prvem odpiranju vsebnika: 10 ur
Shelf life after first opening the container: 10 hours.
Rok uporabnosti po prvem odpiranju vsebnika je 10 ur.
Shelf life after first opening the container: 24 hours (store at 2 C – 8 C).
Rok uporabnosti po prvem odpiranju vsebnika: 24 ur (shranjujte pri 2 C–8 C).
Shelf life after first opening the container: 28 days
Rok uporabnosti odprte viale: 28 dni.
Shelf life after first opening the container: 28 days.
Rok uporabnosti po prvem odpiranju stične ovojnine: 28 dni.
Shelf life after first opening the container: 3 months
Rok uporabnosti po prvem odpiranju vsebnika je 3 mesece.
Shelf life after first opening the container: 3 months.
Rok uporabnosti po prvem odprtju je 3 mesece.
Shelf life after first opening the container: 4 weeks.
Rok uporabnosti po prvem odpiranju vsebnika: 4 tedne.
Shelf life after first opening the container: 8 hours.
Rok uporabnosti po prvem odpiranju vsebnika: 8 ur
Shelf life after first opening the immediate packaging (removal of the cap): 2 weeks.
Rok uporabnosti po prvem odpiranju stične ovojnine (odstranitev pokrovčka): 2 tedna.
Shelf life after first opening the immediate packaging: 1 month.
Rok uporabnosti po prvem odpiranju stične ovojnine: 1 mesec
Shelf life after first opening the immediate packaging: 10 hours stored at 15 ºC to 25 ºC.
Rok uporabnosti po prvem odpiranju stične ovojnine: 10 ur hranjeno pri 15ºC do 25ºC.
Shelf life after first opening the immediate packaging: 10 hours stored at 15 ºC to 25 ºC.
Rok uporabnosti po prvem odpiranju stične ovojnine: 10 ur, če je shranjeno pri 15 ºC do 25ºC.
Shelf life after first opening the immediate packaging: 28 days
Rok uporabnosti po prvem odpiranju stične ovojnine: 28 dni
Shelf life after first opening the immediate packaging: 28 days.
Rok uporabnosti odprte viale: 28 dni.
Shelf life after first opening the immediate packaging: 28 days.
Rok uporabnosti po prvem odpiranju stične ovojnine: 28 dni
Shelf life after first opening the immediate packaging: 5 weeks Shelf life of the medicated drinking water: 24 hours.
Rok uporabnosti po prvem odpiranju stične ovojnine: 5 tednov Rok uporabnosti vode za pitje s primešanim zdravilom: 24 ur.
Shelf life after first opening the immediate packaging: 6 months.
Rok uporabnosti po prvem odpiranju neposredne ovojnine: 6 mesecev.
Shelf life after first opening the immediate packaging: 6 months.
Rok uporabnosti po prvem odpiranju vsebnika: 6 mesecev
Shelf life after first opening the immediate packaging: 8 months.
Rok uporabnosti po prvem odpiranju stične ovojnine: 8 mesecev.
Shelf life after first opening the immediate packaging: immediately
Rok uporabnosti po prvem odpiranju vsebnika: tako.
Shelf life after first opening the immediate packaging: immediately
Rok uporabnosti po prvem odpiranju vsebnika: takoj.
Shelf life after first opening the immediate packaging: immediately after broaching.
Rok uporabnosti po prvem odpiranju vsebnika: tako po prvem odpiranju.